Improved delivery of the anticancer agent citral using BSA nanoparticles and polymeric wafers
Benjamin White,1 Anna Evison,1 Eszter Dombi,1 Helen E Townley1,2 1Nuffield Department of Obstetrics and Gynaecology, Women’s Centre, John Radcliffe Hospital, 2Department of Engineering Science, Oxford University, Oxford, UK Abstract: Rhabdomyosarcoma (RMS) is the most common soft tissue sa...
Guardado en:
Autores principales: | White B, Evison A, Dombi E, Townley HE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7e9bf07be644b07993056d6c9e973a8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin [Corrigendum]
por: Masarudin MJ, et al.
Publicado: (2016) -
Potential of magnetic nanoparticles for targeted drug delivery
por: Yang HW, et al.
Publicado: (2012) -
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin
por: Masarudin MJ, et al.
Publicado: (2015) -
Polymeric nanoparticles loaded with the 3,5,3´-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics
por: dos Santos KC, et al.
Publicado: (2012) -
Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin
por: Akbarzadeh A, et al.
Publicado: (2012)